Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if a sizable myocardial infarction (heart attack) results in negative changes to renal structure and function (i.e. has a negative impact on the kidneys).
To determine if the renal response to a myocardial infarction is a predictor of the patients future health.
Chronic heart and kidney disease are increasingly common in Western society. Both conditions are associated with frequent hospitalisation and increased mortality. Furthermore, there are mechanistic reasons why one condition may beget the other; the so-called "cardiorenal syndrome". The investigators therefore wish to determine if a sizable myocardial infarction (heart attack) results in negative changes to renal structure and function (i.e. has a negative impact on the kidneys). The investigators also wish to determine if the renal response to a myocardial infarction is a predictor of the patients future health. To do this the investigators will measure markers of kidney function at the time of the heart attach, at discharge, 1 month, 6 months and 12 months and correlate this with the patients clinical condition.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 - Control | Non-Q wave MI subjects with normal cardiac and renal function (defined as eGFR >60ml/min) not undergoing a cardiac procedure involving contrast will serve as "control" for renal injury subjects. | ||
| Group 2 - stable CAD or non-Q wave MI | Patients undergoing coronary angiography +/- PCI for stable CAD or non-Q wave MI with normal cardiac and renal function (defined as eGFR >60ml/min) will control for the contrast STEMI patients are likely to receive as part of their post-MI management | ||
| Group 3 - Acute STEMI without chronic kidney disease | Acute STEMI patients (n=40), without chronic kidney disease (defined as eGFR ≥60ml/min). | ||
| Group 4 - Acute STEMI with kidney disease | Acute STEMI patients (n=40), with evidence of background chronic kidney disease (eGFR <60ml/min). |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| changes in renal function and structure | Baseline, discharge, 1 month, 6 months and 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| renal response to myocardial infarction | baseline, discharge, 1 month, 6 months and 12 months |
Not provided
Inclusion Criteria:
Age > 18 years
Have provided written informed consent
Group 1:
Group 2:
Group 3:
Group 4:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients who have presented to the Emergency Department with chest pain caused by a possible myocardial infarction.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Henry Krum, MBBS FRACP PhD | Alfred Hospital/Monash.University | Principal Investigator |
| Henry Krum, MBBS FRACP PhD | Alfred Hospital/Monash University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alfred Hospital | Melbourne | Victoria | 3004 | Australia |
Not provided
| ID | Term |
|---|---|
| D009203 | Myocardial Infarction |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood samples to measure bio-markers
| D007238 |
| Infarction |
| D007511 | Ischemia |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009336 | Necrosis |